Promising disinhibition drug trial halted after just one patient
NCT ID NCT02534038
First seen May 14, 2026 · Last updated May 16, 2026 · Updated 1 time
Summary
This study tested a drug called AVP-786 to see if it could help control disinhibition—acting without thinking—in people with brain diseases like Alzheimer's or frontotemporal dementia. The trial was stopped early after enrolling only one participant, so no conclusions can be drawn about the drug's safety or effectiveness.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DISINHIBITION SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cleveland Clinic Lou Ruvo Center for Brain Health
Las Vegas, Nevada, 89106, United States
Conditions
Explore the condition pages connected to this study.